EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways

Ayman E Abdelaziz, Ahmed A Shokeir, Basem I Awad, Amira Awadalla, A M Abdelghany, Omali Y El-Khawaga

Biomaterials and Biosystems · 2026-12 · 24 · 100147

DOI: 10.1016/j.bbiosy.2026.100147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials and Biosystems, 2026-12. Verfasst von Ayman E Abdelaziz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Division, Chemistry Department, Mansoura University, Mansoura, 35516, Egypt. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mansoura University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is characterized by progressive renal dysfunction associated with oxidative stress, inflammation, apoptosis, podocyte injury, and fibrotic remodeling. Adriamycin (ADR)-induced nephropathy is a widely used experimental model that reproduces key features of CKD, including proteinuria, glomerular and tubular injury, and renal fibrosis. Green-synthesized selenium nanoparticles (SeNPs) have emerged as potential renoprotective agents owing to their antioxidant activity and favorable biocompatibility.

Objective

This study investigated the renoprotective efficacy of Mentha-mediated biosynthesized SeNPs against ADR-induced CKD in rats and explored the underlying molecular mechanisms.

Methods

SeNPs were biosynthesized using sodium selenite and Mentha extract as reducing and capping agent. The synthesized nanoparticles were characterized by UV-visible spectroscopy, transmission electron microscopy (TEM), zeta size and zeta potential analysis, X-ray diffraction (XRD), and Fourier-transform infrared spectroscopy (FTIR). Eighteen male Sprague-Dawley rats were allocated into control, ADR-induced CKD, and ADR + SeNPs groups. At the end of the experimental period, renal function markers, oxidative stress parameters, proteinuria, histopathological alterations, alpha smooth muscle actin (α-SMA) immunoreactivity, and the mRNA expression of apoptotic, inflammatory, and fibrotic genes were assessed.

Results

Characterization confirmed the formation of predominantly spherical SeNPs with a primary particle size of approximately 45-50 nm, a crystalline trigonal selenium structure, moderate colloidal stability, and surface functional groups consistent with biological capping. ADR administration caused significant renal dysfunction, increased urinary protein-to-creatinine ratio (UPCR), decreased renal Wilms tumor 1 (WT1) protein concentration, increased malondialdehyde (MDA), reduced superoxide dismutase (SOD) activity, severe histopathological damage. ADR also increased collagen deposition and α-SMA immunoreactivity and upregulation of Bax, p53, TNF-α, TGF-β, and Collagen-1 genes. SeNPs treatment improved serum renal-function parameters, significantly reduced UPCR, increased renal WT1 concentration, restored SOD activity, decreased MDA levels, and restored renal histoarchitecture. SeNPs also reduced α-SMA immunoreactivity, attenuated fibrotic alterations, and downregulated pro-apoptotic, pro-inflammatory, and pro-fibrotic gene expressions.

Conclusion

Mentha-derived SeNPs effectively attenuated ADR-induced CKD through coordinated antioxidant, anti-inflammatory, anti-apoptotic, and anti-fibrotic actions. These findings highlight the therapeutic potential of green-synthesized SeNPs as a promising nano-based therapeutic approach for chronic renal injury.

Schlagwörter

Stichwörter der Autor:innen

Adriamycin nephropathyApoptosisChronic kidney diseaseMentha extractOxidative stressRenal fibrosisSelenium nanoparticles

Autor:innen und Institutionen

  • Biochemistry Division, Chemistry Department, Mansoura University, Mansoura, 35516, Egypt.
  • Urology and Nephrology Center, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
  • Neurosurgery Department, Director of the Medical Experimental Research Center- Faculty of Medicine-Mansoura University, Mansoura, 35516, Egypt.
  • Oncology Center, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
  • Spectroscopy Department, Physics Research Institute, National Research Centre, 33 Elbehouth st., Dokki, Giza, 12311, Egypt.
  • Nanotechnology Research Unit, Research Center, Horus University, New Damietta, Egypt.

Förderung

  • Mansoura University

Zitieren

APA

Abdelaziz, A. E., Shokeir, A. A., Awad, B. I., Awadalla, A., Abdelghany, A. M., & El-Khawaga, O. Y. (2026). Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways. Biomaterials and Biosystems, 24, 100147. https://doi.org/10.1016/j.bbiosy.2026.100147

Vancouver

Abdelaziz AE, Shokeir AA, Awad BI, Awadalla A, Abdelghany AM, El-Khawaga OY. Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways. Biomaterials and Biosystems. 2026;24:100147. doi:10.1016/j.bbiosy.2026.100147

BibTeX
@article{Abdelaziz2026,
  author = {Abdelaziz, Ayman E and Shokeir, Ahmed A and Awad, Basem I and Awadalla, Amira and Abdelghany, A M and El-Khawaga, Omali Y},
  title = {Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways},
  journal = {Biomaterials and Biosystems},
  year = {2026},
  volume = {24},
  pages = {100147},
  doi = {10.1016/j.bbiosy.2026.100147}
}
Kostenlos starten →